Dec 7 (Reuters) - Willow Biosciences Inc WLLW.TO :
* WILLOW FURTHER OPTIMIZES ITS BUSINESS TO FOCUS ON
NEAR-TERM
REVENUE GENERATION AND REDUCE CASH BURN
* WILLOW BIOSCIENCES INC- HAS TAKEN ADDITIONAL STEPS TO
FOCUS ON
NEAR-TERM REVENUE GENERATION, PROTECT ITS BALANCE SHEET AND
REDUCE ITS CASH BURN
* WILLOW BIOSCIENCES INC- AN EXTENSIVE REVIEW OF CO'S
WORKFLOWS
RESULTED IN TOTAL REDUCTION OF NON-RESEARCH AND DEVELOPMENT
WORKFORCE OF EIGHT PERSONS
* WILLOW BIOSCIENCES INC- CURRENT TOTAL HEADCOUNT OF 31 OF
WHICH
77% ARE IN RESEARCH AND DEVELOPMENT AND OPERATIONS
* WILLOW BIOSCIENCES INC- INTENDS TO APPROVE A FULLY FUNDED
BUDGET
WHICH COVERS ENTIRETY OF 2023
Source text for Eikon: ID:nCNWCDw6xa
Further company coverage: WLLW.TO
((Reuters.Briefs@thomsonreuters.com;))